LALPATHLABstockDr Lal Pathlabs Ltd
₹1,644.8
▲+0.26%
Open
₹1,655.1
High
₹1,693.9
Low
₹1,636.3
Volume
668.4K
Price chart
Daily close · downsampled 5-year history
2021-06-21 · ₹1,575.682026-06-18 · ₹1,666.2
Instrument details
- MB Code
- MBEQU1729
- Type
- stock
- ISIN
- INE600L01024
- BSE
- 539524
- Industry
- Healthcare Services
Latest earnings
Q4FY26 declared
- Quarter
- Mar 2026
- Revenue
- 702.7 Cr
- Net profit
- 132.2 Cr
- EPS
- 7.85
- YoY revenue
- +16.61%
Price returns
Historical performance
- 1 day
- +0.95%
- 1 month
- -2.27%
- 3 months
- +27.17%
- 1 year
- +14.58%
- 3 years
- +57.10%
- 5 years
- +4.74%
Technicals
Indicator consensus
Bullish
36
Neutral
7
Bearish
3
RSI 84.70(Bearish)
Company documents
Annual reports, concalls, presentations
Concall transcripts
82Investor presentations
116Corporate announcements
282Corporate timeline
Price chart events · 1 year
Bonus
2025-12-19
{"bonusRatio":"1:1"}
Dividend
2025-08-06
{"amount":6}
Dividend
2025-11-07
{"amount":7}
Dividend
2026-02-05
{"amount":3.5}
Dividend
2026-06-25
{"amount":4}
Earnings
2026-01-30
{"actualRevenue":6598000000,"estimateRevenue":6796000000,"revenueSurprise":-198000000,"revenueSurprisePercent":-2.913478516774573,"actualEPS":7.209,"estimateEPS":6.94212,"surprise":0.2668799999999996,"surprisePercent":3.844358783772098}
Earnings
2026-04-30
{"actualRevenue":7027000000,"estimateRevenue":6862000000,"revenueSurprise":165000000,"revenueSurprisePercent":2.404546779364617,"actualEPS":7.85,"estimateEPS":7.696104,"surprise":0.1538959999999996,"surprisePercent":1.999661127240479}
Earnings
2025-10-31
{"actualRevenue":7306000000,"estimateRevenue":7524000000,"revenueSurprise":-218000000,"revenueSurprisePercent":-2.897395002658161,"actualEPS":9.005,"estimateEPS":9.251909999999999,"surprise":-0.246909999999998,"surprisePercent":-2.668746237263419}
Earnings
2025-07-31
{"actualRevenue":6698000000,"estimateRevenue":6846000000,"revenueSurprise":-148000000,"revenueSurprisePercent":-2.161846333625475,"actualEPS":7.925,"estimateEPS":7.30116,"surprise":0.6238399999999995,"surprisePercent":8.544395685069214}
News
2026-05-24
{"description":"Dr Lal PathLabs reported Q2 FY26 profit up 16% YoY to ₹152 crore and announced a ₹7 interim dividend along with a 1:1 bonus issue, signaling strong earnings and shareholder returns.","url":"https://www.livemint.com/topic/dr.-lal-pathlabs","sentiment":"Positive","domain":"Mint"}